Literature DB >> 20669547

[Emerging multidrug-resistant microorganisms among travelers returning to France and persons repatriated from foreign hospitals].

Didier Lepelletier1, Antoine Andremont, Patrick Choutet.   

Abstract

The spread of multidrug-resistant bacteria has become a major problem in France in recent years, owing to increasing antibiotic exposure, growing international exchanges, repatriation of hospitalized French patients, and treatment of French and foreign travelers in French hospitals. This article examines how different pathogens may become endemic in France.

Entities:  

Mesh：

Year:  2009        PMID： 20669547      PMCID： PMC7111033     

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN： 0001-4079            Impact factor:   0.144


  42 in total

1.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France.

Authors:  Thierry Naas; Patrice Nordmann; Gérard Vedel; Claire Poyart
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.

Authors:  Gaelle Cuzon; Thierry Naas; Marie Claude Demachy; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

3.  Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1.

Authors:  Laurent Dortet; Irina Radu; Valérie Gautier; François Blot; Elisabeth Chachaty; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2007-11-20       Impact factor: 5.790

4.  Evaluation of repatriation parameters: does medical history matter?

Authors:  Sjoerd Greuters; Herman M T Christiaans; Bart Veenings; Stephan A Loer; Christa Boer
Journal:  J Travel Med       Date:  2009 Jan-Feb       Impact factor: 8.490

5.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 6.  The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa.

Authors:  Matthew E Falagas; Patra K Koletsi; Ioannis A Bliziotis
Journal:  J Med Microbiol       Date:  2006-12       Impact factor: 2.472

7.  Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.

Authors:  Neil Woodford; Jiancheng Zhang; Marina Warner; Mary E Kaufmann; Jorge Matos; Alan Macdonald; Daniel Brudney; David Sompolinsky; Shiri Navon-Venezia; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2008-09-23       Impact factor: 5.790

Review 8.  Debate-guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked.

Authors:  J E McGowan
Journal:  J Hosp Infect       Date:  2004-08       Impact factor: 3.926

Review 9.  Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.

Authors:  M Souli; I Galani; H Giamarellou
Journal:  Euro Surveill       Date:  2008-11-20

10.  Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Authors:  Francois Vandenesch; Timothy Naimi; Mark C Enright; Gerard Lina; Graeme R Nimmo; Helen Heffernan; Nadia Liassine; Michèle Bes; Timothy Greenland; Marie-Elisabeth Reverdy; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.